Y. Inaba

1.8k citations

37 papers · 1.4k · h-index 20

Impact in

Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Geriatrics and Gerontology top 10%

Papers in

Molecular Biology 13
Cell Biology 10
- Biotin and Related Studies 7

Co-authors: Keiko Yamamoto (10 shared papers)Toshimasa Itoh (5 shared papers)Hiroshi Inoue (19 shared papers)Louise Fairall (1 shared paper)Bálint L. Bálint (1 shared paper)László Nagy (1 shared paper)Attila Szántó (1 shared paper)John W. R. Schwabe (1 shared paper)
Journals: Journal of Medicinal Chemistry (5 papers)Nature Communications (3 papers)PLoS ONE (3 papers)Diabetes (2 papers)Endocrinology (2 papers)
Partner nations: Japan United States China

In The Last Decade

Y. Inaba

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Y. Inaba

Since Specialization

Citations

This map shows the geographic impact of Y. Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Inaba more than expected).

Fields of papers citing papers by Y. Inaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Inaba. The network helps show where Y. Inaba may publish in the future.

Co-authors

The 25 scholars most cited alongside Y. Inaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Y. Inaba Line = papers co-authored together Y. Inaba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structural basis for the activation of PPARγ by oxidized fatty acids Nature Structural & Molecular Biology ·Toshimasa Itoh, Louise Fairall, Kush Amin, Y. Inaba, Attila Szántó, Bálint L. Bálint, László Nagy, Keiko Yamamoto, John W. R. Schwabe	2008	373
2	The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism Nature Communications ·Lihua Jin, Xuhui Feng, Hui Rong, Zhifu Pan, Y. Inaba, Lin Qiu, Weili Zheng, Shengchen Lin, Rui Wang, Zhao Wang, Shanshan Wang, Hongyan Liu, Song Li, Wen Xie, Yong Li	2013	120
3	Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein Nature Communications ·Hitoshi Watanabe, Y. Inaba, Kumi Kimura, Michihiro Matsumoto, Shuichi Kaneko, Masato Kasuga, Hiroshi Inoue	2017	75
4	Central Insulin Action Activates Kupffer Cells by Suppressing Hepatic Vagal Activation via the Nicotinic Alpha 7 Acetylcholine Receptor Cell Reports ·Kumi Kimura, Mamoru Tanida, Naoto Nagata, Y. Inaba, Hitoshi Watanabe, Mayumi Nagashimada, Tsuguhito Ota, Shun‐ichiro Asahara, Yoshiaki Kido, Michihiro Matsumoto, Koji Toshinai, Masamitsu Nakazato, Toshishige Shibamoto, Shuichi Kaneko, Masato Kasuga, Hiroshi Inoue	2016	67
5	PDGFRβ Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity Diabetes ·Yasuhiro Onogi, Tsutomu Wada, Chie Kamiya, Kento Inata, Takatoshi Matsuzawa, Y. Inaba, Kumi Kimura, Hiroshi Inoue, Seiji Yamamoto, Yoko Ishii, Daisuke Koya, Hiroshi Tsuneki, Masakiyo Sasahara, Toshiyasu Sasaoka	2017	65
6	Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids PLoS ONE ·Keita Watanabe, Miki Igarashi, Xuan Li, Akiho Nakatani, Junki Miyamoto, Y. Inaba, Asuka Sutou, Tsutomu Saito, Takumi Sato, Nobuhiko Tachibana, Hiroshi Inoue, Ikuo Kimura	2018	55
7	Histidine Augments the Suppression of Hepatic Glucose Production by Central Insulin Action Diabetes ·Kumi Kimura, Yusuke Nakamura, Y. Inaba, Michihiro Matsumoto, Yoshiaki Kido, Shun‐ichiro Asahara, Tomokazu Matsuda, Hiroshi Watanabe, Akifumi Maeda, Fuyuhiko Inagaki, Chisato Mukai, Kiyoshi Takeda, Shizuo Akira, Tsuguhito Ota, Hajime Nakabayashi, Shuichi Kaneko, Masato Kasuga, Hiroshi Inoue	2013	53
8	Vitamin D3 Derivatives with Adamantane or Lactone Ring Side Chains are Cell Type-Selective Vitamin D Receptor Modulators Molecular Pharmacology ·Y. Inaba, Keiko Yamamoto, Nobuko Yoshimoto, Manabu Matsunawa, Shigeyuki Uno, Sachiko Yamada, Makoto Makishima	2007	45
9	A New Class of Vitamin D Analogues that Induce Structural Rearrangement of the Ligand-Binding Pocket of the Receptor Journal of Medicinal Chemistry ·Y. Inaba, Nobuko Yoshimoto, Yuta Sakamaki, Makoto Nakabayashi, Teikichi Ikura, Hirokazu Tamamura, Nobutoshi Ito, Masato Shimizu, Keiko Yamamoto	2009	43
10	Dietary Mung Bean Protein Reduces Hepatic Steatosis, Fibrosis, and Inflammation in Male Mice with Diet-Induced, Nonalcoholic Fatty Liver Disease Journal of Nutrition ·Hitoshi Watanabe, Y. Inaba, Kumi Kimura, Shun‐ichiro Asahara, Yoshiaki Kido, Michihiro Matsumoto, Takayasu Motoyama, Nobuhiko Tachibana, Shuichi Kaneko, M. Kohno, Hiroshi Inoue	2016	40
11	Growth arrest and DNA damage‐inducible 34 regulates liver regeneration in hepatic steatosis in mice Hepatology ·Y. Inaba, Tomoko Furutani, Kumi Kimura, Hitoshi Watanabe, Sanae Haga, Yoshiaki Kido, Michihiro Matsumoto, Yasuhiko Yamamoto, Kenichi Harada, Shuichi Kaneko, Seiichi Oyadomari, Michitaka Ozaki, Masato Kasuga, Hiroshi Inoue	2014	39
12	The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice Nature Communications ·Y. Inaba, Emi Hashiuchi, Hitoshi Watanabe, Kumi Kimura, Yu Oshima, K. Tsuchiya, Shin Murai, Chiaki Takahashi, Michihiro Matsumoto, Shigetaka Kitajima, Yasuhiko Yamamoto, Masao Honda, Shun‐ichiro Asahara, Kim Ravnskjær, Shin‐ichi Horike, Shuichi Kaneko, Masato Kasuga, Hiroyasu Nakano, Kenichi Harada, Hiroshi Inoue	2023	38
13	Farnesoid X Receptor Induces Murine Scavenger Receptor Class B Type I via Intron Binding PLoS ONE ·Guodong Li, Ann Thomas, Jessica A. Williams, Bo Kong, Jie Liu, Y. Inaba, Wen Xie, Grace L. Guo	2012	36
14	Nicotinic alpha‐7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non‐alcoholic steatohepatitis Journal of Diabetes Investigation ·Kumi Kimura, Y. Inaba, Hitoshi Watanabe, Toshiya Matsukawa, Michihiro Matsumoto, Hiroshi Inoue	2018	29
15	Toxicity study of europium chloride in rats. PubMed ·Yoshiyuki Ogawa, S. Suzuki, K. Naito, Mere Erika Saito, Eiichi Kamata, Akihiko Hirose, Atsushi Ono, Toyozo Kaneko, Masatoshi Chiba, Y. Inaba	1995	27
16	Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor PLoS ONE ·Jessica A. Williams, Ann Thomas, Guodong Li, Bo Kong, Le Zhan, Y. Inaba, Wen Xie, Wen‐Xing Ding, Grace L. Guo	2012	26
17	Potent Antagonist for the Vitamin D Receptor: Vitamin D Analogues with Simple Side Chain Structure Journal of Medicinal Chemistry ·Yuta Sakamaki, Y. Inaba, Nobuko Yoshimoto, Keiko Yamamoto	2010	26
18	2-Methylene 19-nor-25-dehydro-1α-hydroxyvitamin D3 26,23-lactones: Synthesis, biological activities and molecular basis of passive antagonism Bioorganic & Medicinal Chemistry ·Nobuko Yoshimoto, Y. Inaba, Sachiko Yamada, Makoto Makishima, Masato Shimizu, Keiko Yamamoto	2007	22
19	Structural Basis for Inhibition of Carboxypeptidase B by Selenium-Containing Inhibitor: Selenium Coordinates to Zinc in Enzyme Journal of Medicinal Chemistry ·Nobuko Yoshimoto, Toshimasa Itoh, Y. Inaba, Hidemi Ishii, Keiko Yamamoto	2013	22
20	p62/SQSTM1 Plays a Protective Role in Oxidative Injury of Steatotic Liver in a Mouse Hepatectomy Model Antioxidants and Redox Signaling ·Sanae Haga, Takeaki Ozawa, Yuma Yamada, Naoki Morita, I Nagashima, Hiroshi Inoue, Y. Inaba, Natsumi Noda, Riichiro Abe, Kazuo Umezawa, Michitaka Ozaki	2014	20

About Y. Inaba

Y. Inaba is a scholar working on Molecular Biology, Cell Biology, Physiology, Pathology and Forensic Medicine and Epidemiology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Vitamin D Research Studies (8 papers), Adipose Tissue and Metabolism (7 papers), Biotin and Related Studies (7 papers), Pancreatic function and diabetes (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Estrogen and related hormone effects (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Diet and metabolism studies (4 papers). The work is most often cited by research in Biochemistry (107 citations), Geriatrics and Gerontology (43 citations), Pathology and Forensic Medicine (187 citations), Molecular Biology (635 citations) and Physiology (237 citations). Y. Inaba has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Keiko Yamamoto, Toshimasa Itoh, Hiroshi Inoue, Louise Fairall, Bálint L. Bálint, László Nagy, Attila Szántó, John W. R. Schwabe, Kumi Kimura and Michihiro Matsumoto. Their work appears in journals such as Journal of Medicinal Chemistry, Nature Communications, PLoS ONE, Diabetes and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Y. Inaba

Impact in

Papers in i

In The Last Decade

Y. Inaba

Peers

Countries citing papers authored by Y. Inaba

Fields of papers citing papers by Y. Inaba

All Works

About Y. Inaba

Explore authors with similar magnitude of impact

Papers in